Aspirin and the risk of colorectal cancer in relation to the expression of 15-hydroxyprostaglandin dehydrogenase (HPGD)
about
Lipidome in colorectal cancerEpidemiology of colorectal cancerGenetics and Genetic Biomarkers in Sporadic Colorectal CancerThe evolving role of nonsteroidal anti-inflammatory drugs in colon cancer prevention: a cause for optimismCancer prevention and control: alarming challenges in ChinaMolecular pathological epidemiology: new developing frontiers of big data science to study etiologies and pathogenesis.Proceedings of the second international molecular pathological epidemiology (MPE) meetingChemo/Dietary prevention of cancer: perspectives in ChinaIntegration of molecular pathology, epidemiology and social science for global precision medicine.Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine.Transforming Cancer Prevention through Precision Medicine and Immune-oncology.Prediagnosis aspirin use and outcomes in a prospective cohort of esophageal cancer patients.Spectral biomarkers for chemoprevention of colonic neoplasia: a placebo-controlled double-blinded trial with aspirin.Gastroprotective [6]-Gingerol Aspirinate as a Novel Chemopreventive Prodrug of Aspirin for Colon Cancer.ASPirin Intervention for the REDuction of colorectal cancer risk (ASPIRED): a study protocol for a randomized controlled trial.Sex-Specific Associations between Particulate Matter Exposure and Gene Expression in Independent Discovery and Validation Cohorts of Middle-Aged Men and Women.The past 10 years of gastroenterology and hepatology-reflections and predictions.Biomarker-directed Targeted Therapy in Colorectal Cancer.Drug repurposing in oncology--patient and health systems opportunities.Aspirin and colorectal cancer: the promise of precision chemoprevention.Prostaglandin E2 Activates YAP and a Positive-Signaling Loop to Promote Colon Regeneration After Colitis but Also Carcinogenesis in Mice.Colonic Saturated Fatty Acid Concentrations and Expression of COX-1, but not Diet, Predict Prostaglandin E2 in Normal Human Colon Tissue.TISSUE REGENERATION. Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration.Sex Differential in 15-Hydroxyprostaglandin Dehydrogenase Levels in the Lumen of Human Intracranial Aneurysms.Potent suppression of both spontaneous and carcinogen-induced colitis-associated colorectal cancer in mice by dietary celastrol supplementation.Colorectal Cancers: An Update on Their Molecular Pathology.Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine.Concerted actions of ameliorated colitis, aberrant crypt foci inhibition and 15-hydroxyprostaglandin dehydrogenase induction by sonic hedgehog inhibitor led to prevention of colitis-associated cancer.Integration of pharmacology, molecular pathology, and population data science to support precision gastrointestinal oncology.Inverse expression of prostaglandin E2-related enzymes highlights differences between diverticulitis and inflammatory bowel disease.Cancer prevention by aspirin in children with Constitutional Mismatch Repair Deficiency (CMMRD)Bacterial infections and cancerAdvances in antitumor effects of NSAIDs
P2860
Q26766296-37936315-B10C-47B7-8B4E-71E609CA4FDEQ28067871-1BC9FCC1-93ED-46C5-B13F-666F7A3AC28BQ28084346-53DF31D0-2B8B-4F71-9927-8C897B6707A6Q28087427-7A8C0DD3-FA48-4E05-9DC2-E86406CB1F0DQ28396786-D4790300-642B-4A52-AC77-FED703CE29FDQ30244608-20171CB9-C072-4D8B-8E9B-5EC360105798Q34475686-CD5ADB92-77F8-46B4-AC2B-671B1CAC49E4Q34604351-D36A99E9-6834-488D-845B-D2AEAAE8D8A3Q36463854-80155AE9-4941-48A1-9543-36D5A7C2A82CQ36968401-71B69672-A145-404B-A76D-E60D686456F9Q37114360-5DDEC05E-DE6C-4AE3-9EF8-002CCD862B3BQ37361447-8BFAE54B-5F0B-433B-8B30-3FD981246C17Q37413259-6E17E730-00FA-4CB9-AB6C-964FC8F45565Q37571099-45241499-7130-4AB7-9F20-A0C8FDDDB257Q37618698-F4461A61-E4B2-4C4A-B87D-77B063341795Q37738932-B71D921E-144E-4622-ADAD-9AC6ABC90DA7Q38257761-2A58D32F-05DA-47B8-8F50-F7E6562BEC4DQ38383343-74DAC869-0A9E-41F6-BDC4-5D0CD301CBB3Q38611707-24E2C47E-E5AD-4BC9-AA9F-F71F5D7EF403Q38730064-82B0DE9D-23BE-4278-810F-5F8E97CB867AQ38730228-4A0DCF0A-3291-4843-9719-64C0489E8808Q39467213-3114F342-594A-4927-9FC7-7C874751E616Q42404774-EEEB8AB7-AC73-424F-A117-C3C6544E6008Q47107594-3B8C9891-E3F3-44A0-8CA9-C87C449051D1Q47720507-7394A938-A8ED-408F-929A-3D3AC844D263Q48182864-E8C4889B-E3AF-4C78-B883-29C2401AD17EQ50043586-4A0DF2A5-896E-4458-9C52-E4FD4DE5D6C5Q52909064-06752F30-7DA9-4719-8F48-9225BC313415Q53601791-A9CB2B9C-452F-41D6-81E7-12EEF678A1E3Q53614343-3BCF61DC-5125-4658-BB41-75526CBD5123Q57316200-B0999F91-6F1F-40EE-8223-4204C0FD0F53Q57802480-69767454-625F-4593-AA45-F6136B5BCE77Q58561290-D973D09F-70C4-4440-982A-F32BE8699BCC
P2860
Aspirin and the risk of colorectal cancer in relation to the expression of 15-hydroxyprostaglandin dehydrogenase (HPGD)
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Aspirin and the risk of colore ...... taglandin dehydrogenase (HPGD)
@ast
Aspirin and the risk of colore ...... taglandin dehydrogenase (HPGD)
@en
type
label
Aspirin and the risk of colore ...... taglandin dehydrogenase (HPGD)
@ast
Aspirin and the risk of colore ...... taglandin dehydrogenase (HPGD)
@en
prefLabel
Aspirin and the risk of colore ...... taglandin dehydrogenase (HPGD)
@ast
Aspirin and the risk of colore ...... taglandin dehydrogenase (HPGD)
@en
P2093
P2860
P1476
Aspirin and the risk of colore ...... taglandin dehydrogenase (HPGD)
@en
P2093
Andrew T Chan
Aya Kuchiba
Eunyoung Cho
Mai Yamauchi
Reiko Nishihara
Sanford D Markowitz
Seungyoun Jung
Shuji Ogino
Stephen P Fink
P2860
P304
P356
10.1126/SCITRANSLMED.3008481
P407
P577
2014-04-01T00:00:00Z